; and (iii) encourage access to non-opioid alternatives when medically appropriate. (B) Prohibition on requiring fail first schemes The Secretary shall prohibit PDP sponsors from requiring fail first schemes, also known as step therapy, with respect to abuse-deterrent opioids. (C) Encouraging equal access The Secretary shall encourage plans to provide equal access to abuse-deterrent opioids on formulary tiers and patient cost-sharing. (D) Abuse-deterrent opioid defined In this paragraph, the term abuse-deterrent opioid means an abuse-deterrent formulation of an opioid, as determined by the Secretary. . (2) Access under private health plans Subpart II of title XXVII of the Public Health Service Act ( 42 U.S.C. 300gg–11 et seq.) is amended by adding at the end the following: 2729. Access to abuse-deterrent opioids (a) In general A group health plan and a health insurance issuer offering group or individual health insurance coverage shall— (1) ensure appropriate access to abuse-deterrent opioids as a prescription drug health benefit under such plan or coverage; (2) provide advanced abuse-deterrent opioid targeting (as determined by the Secretary) for enrollees in the plan or coverage who are identified as at-risk for opioid abuse